Showing results (2041-2050 of 2,173) with videos related to

Sort By:
Pageof 218
Leukemia|May 10, 2017
JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemiasC Delgado-Martin, L K Meyer, B J Huang, et al.
American Journal of Obstetrics and Gynecology|May 7, 2025
Guidelines for antenatal and preoperative care in cesarean delivery: Enhanced Recovery After Surgery Society recommendations (part 1)-2025 updateR Douglas Wilson, David T Monks, Nadir Sharawi, et al.
American Journal of Obstetrics and Gynecology|May 7, 2025
Guidelines for intraoperative care in cesarean delivery: Enhanced Recovery After Surgery Society recommendations (part 2)-2025 updateAaron B Caughey, Pervez Sultan, David T Monks, et al.
Plos Neglected Tropical Diseases|September 27, 2021
Schistosome infection in Senegal is associated with different spatial extents of risk and ecological drivers for Schistosoma haematobium and S. mansoniIsabel J Jones, Susanne H Sokolow, Andrew J Chamberlin, et al.
Journal of Neuromuscular Diseases|February 20, 2025
A Parent Project Muscular Dystrophy-sponsored International Workshop Report on Endocrine and Bone Issues in Patients with Duchenne Muscular Dystrophy: An Ever-changing LandscapeLeanne M Ward, David R Weber, Sze Choong Wong, et al.
Blood|August 9, 2023
Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group studyBrent L Wood, Meenakshi Devidas, Ryan J Summers, et al.
Blood|July 1, 2015
Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232Michael J Borowitz, Brent L Wood, Meenakshi Devidas, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2018
Extended-Duration MK-8591-Eluting Implant as a Candidate for HIV Treatment and PreventionStephanie E Barrett, Ryan S Teller, Seth P Forster, et al.
Pediatric Blood & Cancer|March 11, 2015
Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434Stuart S Winter, Kimberly P Dunsmore, Meenakshi Devidas, et al.
Leukemia|November 2, 2021
Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children's Oncology Group Study AALL0232Michael J Burke, Meenakshi Devidas, Zhiguo Chen, et al.
Pageof 218